Translational and Emerging Therapies

Fii primul care da un review!
320.00 lei (TVA inclus)
Costul de livrare se calculeaza odata cu adaugarea produsului in cos si selectarea localitatii destinatie.

Cod produs/ISBN: 9780367453091

Disponibilitate: La comanda in aproximativ 4 saptamani

Editura: CRC Press

Limba: Engleza

Nr. pagini: 278

Coperta: Softcover

Dimensiuni: 15.24 x 1.52 x 22.61 cm

An aparitie: 2020




Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer. Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, d



Table of Contents:


1. Molecular Biology of Lung Cancer as the Basis for Targeted Therapy

2. Early Clinical Trial Design Issues: Patient Populations, End Points, and Barriers

3. Antiangiogenic Therapy for Lung Cancer: Small-Molecule Inhibitors

4. Antiangiogenic Therapy for Lung Cancer: Antibodies and Other Novel Agents

5. Epidermal Growth Factor Receptor Inhibition in Non–Small Cell Lung Cancer

6. Epidermal Growth Factor Receptor Targeted Therapy—Markers of Sensitivity and Response

7. Other Novel Targeted Therapies in Lung Cancer

8. Lung Cancer Vaccines

9. Advances in Chemoradiation Treatment of Locoregionally Advanced Non–Small Cell Lung Cancer

10. Advances in the Treatment of Brain Metastases

11. Recent Advances in Imaging for Lung Cancer


An aparitie: 2020
Autor: Kishan J. Pandya, Julie R. Brahmer, Manuel Hidalgo
Dimensiuni: 15.24 x 1.52 x 22.61 cm
Editura: CRC Press
Format: Softcover
ISBN: 9780367453091
Limba: Engleza
Nr pag: 278

Clientii nu au adaugat inca opinii pentru acest produs. Fii primul care adauga o parere, folosind formularul de mai jos.

Spune-ne parerea ta despre acest produs

Nota acordata produsului:

Notificare prin e-mail cand apar comentarii noi